vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Rollins, Inc. is the larger business by last-quarter revenue ($906.4M vs $510.9M, roughly 1.8× Genius Sports Ltd). Rollins, Inc. runs the higher net margin — 11.9% vs -12.3%, a 24.2% gap on every dollar of revenue. Rollins, Inc. produced more free cash flow last quarter ($111.2M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 0.8%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

GENI vs ROL — Head-to-Head

Bigger by revenue
ROL
ROL
1.8× larger
ROL
$906.4M
$510.9M
GENI
Higher net margin
ROL
ROL
24.2% more per $
ROL
11.9%
-12.3%
GENI
More free cash flow
ROL
ROL
$41.7M more FCF
ROL
$111.2M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
ROL
ROL
Revenue
$510.9M
$906.4M
Net Profit
$-63.0M
$107.8M
Gross Margin
25.2%
Operating Margin
-11.5%
16.1%
Net Margin
-12.3%
11.9%
Revenue YoY
10.2%
Net Profit YoY
2.5%
EPS (diluted)
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
ROL
ROL
Q1 26
$906.4M
Q4 25
$510.9M
$912.9M
Q3 25
$335.4M
$1.0B
Q2 25
$215.2M
$999.5M
Q1 25
$119.7M
$822.5M
Q4 24
$413.0M
$832.2M
Q3 24
$285.8M
$916.3M
Q2 24
$184.1M
$891.9M
Net Profit
GENI
GENI
ROL
ROL
Q1 26
$107.8M
Q4 25
$-63.0M
$116.4M
Q3 25
$163.5M
Q2 25
$-47.3M
$141.5M
Q1 25
$-25.5M
$105.2M
Q4 24
$-85.5M
$105.7M
Q3 24
$-47.1M
$136.9M
Q2 24
$-35.5M
$129.4M
Gross Margin
GENI
GENI
ROL
ROL
Q1 26
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Operating Margin
GENI
GENI
ROL
ROL
Q1 26
16.1%
Q4 25
-11.5%
17.5%
Q3 25
-15.3%
21.9%
Q2 25
-21.0%
19.8%
Q1 25
-20.3%
17.3%
Q4 24
-18.0%
18.1%
Q3 24
-13.9%
20.9%
Q2 24
-16.8%
20.4%
Net Margin
GENI
GENI
ROL
ROL
Q1 26
11.9%
Q4 25
-12.3%
12.8%
Q3 25
15.9%
Q2 25
-22.0%
14.2%
Q1 25
-21.3%
12.8%
Q4 24
-20.7%
12.7%
Q3 24
-16.5%
14.9%
Q2 24
-19.3%
14.5%
EPS (diluted)
GENI
GENI
ROL
ROL
Q1 26
$0.22
Q4 25
$0.24
Q3 25
$0.34
Q2 25
$0.29
Q1 25
$0.22
Q4 24
$0.22
Q3 24
$0.28
Q2 24
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$280.6M
$116.5M
Total DebtLower is stronger
$650.6M
Stockholders' EquityBook value
$724.5M
$1.4B
Total Assets
$1.1B
$3.2B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
ROL
ROL
Q1 26
$116.5M
Q4 25
$280.6M
$100.0M
Q3 25
$110.2M
$127.4M
Q2 25
$110.2M
$123.0M
Q1 25
$110.2M
$201.2M
Q4 24
$100.3M
$89.6M
Q3 24
$100.3M
$95.3M
Q2 24
$100.3M
$106.7M
Total Debt
GENI
GENI
ROL
ROL
Q1 26
$650.6M
Q4 25
$486.1M
Q3 25
$485.7M
Q2 25
$485.3M
Q1 25
$485.5M
Q4 24
$395.3M
Q3 24
Q2 24
Stockholders' Equity
GENI
GENI
ROL
ROL
Q1 26
$1.4B
Q4 25
$724.5M
$1.4B
Q3 25
$572.4M
$1.5B
Q2 25
$572.4M
$1.4B
Q1 25
$572.4M
$1.4B
Q4 24
$573.0M
$1.3B
Q3 24
$573.0M
$1.3B
Q2 24
$573.0M
$1.2B
Total Assets
GENI
GENI
ROL
ROL
Q1 26
$3.2B
Q4 25
$1.1B
$3.1B
Q3 25
$792.3M
$3.2B
Q2 25
$792.3M
$3.2B
Q1 25
$792.3M
$2.9B
Q4 24
$775.7M
$2.8B
Q3 24
$775.7M
$2.8B
Q2 24
$775.7M
$2.8B
Debt / Equity
GENI
GENI
ROL
ROL
Q1 26
0.47×
Q4 25
0.35×
Q3 25
0.32×
Q2 25
0.34×
Q1 25
0.36×
Q4 24
0.30×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
ROL
ROL
Operating Cash FlowLast quarter
$81.9M
$118.4M
Free Cash FlowOCF − Capex
$69.6M
$111.2M
FCF MarginFCF / Revenue
13.6%
12.3%
Capex IntensityCapex / Revenue
2.4%
0.8%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
ROL
ROL
Q1 26
$118.4M
Q4 25
$81.9M
$164.7M
Q3 25
$-4.8M
$191.3M
Q2 25
$-1.2M
$175.1M
Q1 25
$-14.6M
$146.9M
Q4 24
$14.9M
$188.2M
Q3 24
$-9.2M
$146.9M
Q2 24
$145.1M
Free Cash Flow
GENI
GENI
ROL
ROL
Q1 26
$111.2M
Q4 25
$69.6M
$159.0M
Q3 25
$-14.2M
$182.8M
Q2 25
$-5.8M
$168.0M
Q1 25
$-16.0M
$140.1M
Q4 24
$11.3M
$184.0M
Q3 24
$-11.6M
$139.4M
Q2 24
$136.4M
FCF Margin
GENI
GENI
ROL
ROL
Q1 26
12.3%
Q4 25
13.6%
17.4%
Q3 25
-4.2%
17.8%
Q2 25
-2.7%
16.8%
Q1 25
-13.4%
17.0%
Q4 24
2.7%
22.1%
Q3 24
-4.1%
15.2%
Q2 24
15.3%
Capex Intensity
GENI
GENI
ROL
ROL
Q1 26
0.8%
Q4 25
2.4%
0.6%
Q3 25
2.8%
0.8%
Q2 25
2.1%
0.7%
Q1 25
1.2%
0.8%
Q4 24
0.9%
0.5%
Q3 24
0.9%
0.8%
Q2 24
1.0%
Cash Conversion
GENI
GENI
ROL
ROL
Q1 26
1.10×
Q4 25
1.41×
Q3 25
1.17×
Q2 25
1.24×
Q1 25
1.40×
Q4 24
1.78×
Q3 24
1.07×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons